Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXK7QO
|
||||
| Drug Name |
6-Cyclohexylamino-9-cyclopentyl-9H-purine-2-carbonitrile
|
||||
| Synonyms |
CHEMBL370318
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C17H22N6
|
||||
| Canonical SMILES |
N#Cc1nc(NC2CCCCC2)c3ncn(C4CCCC4)c3n1
|
||||
| InChI |
InChI=1S/C17H22N6/c18-10-14-21-16(20-12-6-2-1-3-7-12)15-17(22-14)23(11-19-15)13-8-4-5-9-13/h11-13H,1-9H2,(H,20,21,22)
|
||||
| InChIKey |
VNUJPTVFFFXCLL-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.